Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Novacyt SA

ALNOV.PA ✓ COMPLIANT ☆ Track — members

Euronext Paris · Healthcare · Biotechnology & Medical Research ·

France Micro Cap Analyst: N/A

Last Close

$0.60

▲ +0.78%

Market Cap $43.34M · Vol 362.63K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$43.34M

Micro Cap

Div Yield

N/A

Annual dividend

EPS Growth

N/A

YoY

RSI (14)

66.04

Momentum

Beta

0.25

vs Market

52W High

$1.20

50.91% below

52W Low

$0.34

76.77% above

Volume

362.63K

Avg 244.09K

P/B

1.03

Price-to-book

ROE

N/A

Return on equity

Free Float

99.94%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Novacyt SA (ALNOV.PA) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does ALNOV.PA pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+17.73%

+23.78%

-0.38%

+26.96%

YTD

+32.48%

+5.71%

-36.83%

-85.04%

Financials & Valuation

TTM · Annual

Total Revenue	$26.98M
Net Income	$-31,596,675.00
Revenue Growth (YoY)	+9.97%
Gross Margin	62.98%
Operating Margin	-51.93%
Net Profit Margin	-117.09%
ROE	N/A
ROA · ROIC	-49.29% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	1.20
P/B	1.03
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	72.59M

Technical Indicators

50-Day SMA	$0.50
200-Day SMA	$0.50
RSI (14)	66.04
Beta	0.25
52-Week High	$1.20
52-Week Low	$0.34

Volume Today	362.63K
Avg Daily Volume (30D)	244.09K
Relative Volume	1.49x
Volatility (10D)	82.77
Volatility (30D)	58.96
Free Float	99.94%

Analyst Consensus

N/A

Current Price $0.60

Mean Target N/A

52W Low$0.34 52W High$1.20

Current

Target

$0.34 $1.20

Current Analyst target

· 0 analysts

Identifiers

ExchangeEuronext Paris

FIGIBBG003CDTG31

ISINFR0010397232

CountryFrance

Sub-IndustryBio Medical Devices

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

MDXG MiMedx Group Inc +1.67% BONS.TA Bonus Biogroup Ltd -1.35% BBLG Bone Biologics Corp -2.86% 2359.HK WuXi AppTec Co Ltd -2.85% ARGX argenx SE -0.66%

Company Profile

Novacyt SA is a France-based company providing biotechnological solutions. The Company develops and markets solutions dedicated to the field of liquid-based cytology and molecular biology. It provides diagnostic products used in oncology, microbiology, haematology, and serology testing. The Company develops secure automated cytology named NovaPrep Processor System. It offers a solution of cytological sampling to help in the detection of precancerous and cancerous lesions. It creates bottles specifically dedicated to the optimization of cell collection. The Company’s range of products includes Bottle Gyn and No Gyn Bottle.